nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—MAP2—epilepsy syndrome	0.178	0.48	CbGaD
Docetaxel—BCL2—epilepsy syndrome	0.087	0.234	CbGaD
Docetaxel—ABCC2—epilepsy syndrome	0.0471	0.127	CbGaD
Docetaxel—ABCG2—epilepsy syndrome	0.0416	0.112	CbGaD
Docetaxel—ABCC2—Levetiracetam—epilepsy syndrome	0.0238	0.0702	CbGbCtD
Docetaxel—CYP1B1—Propofol—epilepsy syndrome	0.0217	0.0641	CbGbCtD
Docetaxel—CYP1B1—Phenobarbital—epilepsy syndrome	0.0208	0.0613	CbGbCtD
Docetaxel—ABCB1—epilepsy syndrome	0.0173	0.0466	CbGaD
Docetaxel—ABCC1—Phenobarbital—epilepsy syndrome	0.0148	0.0435	CbGbCtD
Docetaxel—SLC22A7—Valproic Acid—epilepsy syndrome	0.014	0.0414	CbGbCtD
Docetaxel—ABCC2—Carbamazepine—epilepsy syndrome	0.0137	0.0403	CbGbCtD
Docetaxel—ABCC2—Phenytoin—epilepsy syndrome	0.0123	0.0362	CbGbCtD
Docetaxel—ABCC2—Phenobarbital—epilepsy syndrome	0.0109	0.0322	CbGbCtD
Docetaxel—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0109	0.0322	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00912	0.0269	CbGbCtD
Docetaxel—CYP3A7—Carbamazepine—epilepsy syndrome	0.00912	0.0269	CbGbCtD
Docetaxel—CYP3A7—Phenytoin—epilepsy syndrome	0.00818	0.0241	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00818	0.0241	CbGbCtD
Docetaxel—ABCB1—Levetiracetam—epilepsy syndrome	0.00775	0.0229	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00729	0.0215	CbGbCtD
Docetaxel—CYP3A7—Phenobarbital—epilepsy syndrome	0.00729	0.0215	CbGbCtD
Docetaxel—CYP3A7—Midazolam—epilepsy syndrome	0.00719	0.0212	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00719	0.0212	CbGbCtD
Docetaxel—CYP3A7—Diazepam—epilepsy syndrome	0.00691	0.0204	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00691	0.0204	CbGbCtD
Docetaxel—CYP3A5—Carbamazepine—epilepsy syndrome	0.00684	0.0202	CbGbCtD
Docetaxel—CYP3A5—Phenytoin—epilepsy syndrome	0.00614	0.0181	CbGbCtD
Docetaxel—CYP3A5—Phenobarbital—epilepsy syndrome	0.00547	0.0161	CbGbCtD
Docetaxel—CYP3A5—Midazolam—epilepsy syndrome	0.00539	0.0159	CbGbCtD
Docetaxel—ABCB1—Clobazam—epilepsy syndrome	0.00537	0.0159	CbGbCtD
Docetaxel—CYP3A5—Diazepam—epilepsy syndrome	0.00519	0.0153	CbGbCtD
Docetaxel—ABCB1—Lamotrigine—epilepsy syndrome	0.00517	0.0153	CbGbCtD
Docetaxel—ABCB1—Carbamazepine—epilepsy syndrome	0.00445	0.0131	CbGbCtD
Docetaxel—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00425	0.0125	CbGbCtD
Docetaxel—CYP3A5—Valproic Acid—epilepsy syndrome	0.00409	0.0121	CbGbCtD
Docetaxel—ABCB1—Phenytoin—epilepsy syndrome	0.00399	0.0118	CbGbCtD
Docetaxel—CYP3A4—Felbamate—epilepsy syndrome	0.00395	0.0117	CbGbCtD
Docetaxel—CYP3A4—Trimethadione—epilepsy syndrome	0.00395	0.0117	CbGbCtD
Docetaxel—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00371	0.011	CbGbCtD
Docetaxel—ABCB1—Phenobarbital—epilepsy syndrome	0.00356	0.0105	CbGbCtD
Docetaxel—ABCB1—Midazolam—epilepsy syndrome	0.00351	0.0104	CbGbCtD
Docetaxel—ABCB1—Diazepam—epilepsy syndrome	0.00338	0.00996	CbGbCtD
Docetaxel—CYP3A4—Clonazepam—epilepsy syndrome	0.00336	0.00991	CbGbCtD
Docetaxel—CYP3A4—Clobazam—epilepsy syndrome	0.00322	0.0095	CbGbCtD
Docetaxel—GHRHR—hindbrain—epilepsy syndrome	0.00274	0.0562	CbGeAlD
Docetaxel—CYP3A4—Rufinamide—epilepsy syndrome	0.00274	0.00808	CbGbCtD
Docetaxel—CYP3A4—Carbamazepine—epilepsy syndrome	0.00267	0.00787	CbGbCtD
Docetaxel—CYP3A4—Primidone—epilepsy syndrome	0.00249	0.00735	CbGbCtD
Docetaxel—CYP3A4—Phenytoin—epilepsy syndrome	0.00239	0.00706	CbGbCtD
Docetaxel—CYP3A4—Propofol—epilepsy syndrome	0.00223	0.00659	CbGbCtD
Docetaxel—CYP3A4—Acetazolamide—epilepsy syndrome	0.00213	0.00629	CbGbCtD
Docetaxel—CYP3A4—Phenobarbital—epilepsy syndrome	0.00213	0.00629	CbGbCtD
Docetaxel—CYP3A4—Midazolam—epilepsy syndrome	0.0021	0.00621	CbGbCtD
Docetaxel—CYP3A4—Diazepam—epilepsy syndrome	0.00202	0.00597	CbGbCtD
Docetaxel—CYP3A4—Zonisamide—epilepsy syndrome	0.00197	0.00582	CbGbCtD
Docetaxel—MAP2—telencephalic ventricle—epilepsy syndrome	0.00179	0.0367	CbGeAlD
Docetaxel—CYP3A4—Valproic Acid—epilepsy syndrome	0.00159	0.0047	CbGbCtD
Docetaxel—GHRHR—brainstem—epilepsy syndrome	0.00157	0.0322	CbGeAlD
Docetaxel—CYP3A4—Topiramate—epilepsy syndrome	0.00144	0.00424	CbGbCtD
Docetaxel—Paclitaxel—MAP2—epilepsy syndrome	0.00117	0.401	CrCbGaD
Docetaxel—MAP2—ganglion—epilepsy syndrome	0.00111	0.0229	CbGeAlD
Docetaxel—MAP4—hindbrain—epilepsy syndrome	0.00107	0.022	CbGeAlD
Docetaxel—GHRHR—head—epilepsy syndrome	0.000868	0.0178	CbGeAlD
Docetaxel—MAP2—hindbrain—epilepsy syndrome	0.000846	0.0173	CbGeAlD
Docetaxel—GHRHR—nervous system—epilepsy syndrome	0.000823	0.0169	CbGeAlD
Docetaxel—GHRHR—central nervous system—epilepsy syndrome	0.000792	0.0162	CbGeAlD
Docetaxel—GHRHR—cerebellum—epilepsy syndrome	0.000774	0.0159	CbGeAlD
Docetaxel—MAPT—telencephalon—epilepsy syndrome	0.000695	0.0142	CbGeAlD
Docetaxel—TUBB4A—hindbrain—epilepsy syndrome	0.000653	0.0134	CbGeAlD
Docetaxel—GHRHR—brain—epilepsy syndrome	0.000629	0.0129	CbGeAlD
Docetaxel—MAP4—brainstem—epilepsy syndrome	0.000615	0.0126	CbGeAlD
Docetaxel—MAP4—forebrain—epilepsy syndrome	0.000594	0.0122	CbGeAlD
Docetaxel—Paclitaxel—BCL2—epilepsy syndrome	0.000573	0.196	CrCbGaD
Docetaxel—MAP4—telencephalon—epilepsy syndrome	0.000546	0.0112	CbGeAlD
Docetaxel—MAPT—medulla oblongata—epilepsy syndrome	0.000546	0.0112	CbGeAlD
Docetaxel—BCL2—forebrain—epilepsy syndrome	0.00054	0.0111	CbGeAlD
Docetaxel—KIF11—brain—epilepsy syndrome	0.000535	0.011	CbGeAlD
Docetaxel—NR1I2—head—epilepsy syndrome	0.00052	0.0107	CbGeAlD
Docetaxel—MAPT—midbrain—epilepsy syndrome	0.000499	0.0102	CbGeAlD
Docetaxel—TUBB8—head—epilepsy syndrome	0.000498	0.0102	CbGeAlD
Docetaxel—BCL2—telencephalon—epilepsy syndrome	0.000497	0.0102	CbGeAlD
Docetaxel—EGFR—telencephalon—epilepsy syndrome	0.000491	0.0101	CbGeAlD
Docetaxel—MAPT—spinal cord—epilepsy syndrome	0.000487	0.00998	CbGeAlD
Docetaxel—MAP2—brainstem—epilepsy syndrome	0.000485	0.00994	CbGeAlD
Docetaxel—TUBB8—nervous system—epilepsy syndrome	0.000473	0.00969	CbGeAlD
Docetaxel—MAP2—forebrain—epilepsy syndrome	0.000468	0.00959	CbGeAlD
Docetaxel—TUBB8—central nervous system—epilepsy syndrome	0.000455	0.00933	CbGeAlD
Docetaxel—MAP2—telencephalon—epilepsy syndrome	0.00043	0.00882	CbGeAlD
Docetaxel—MAP4—medulla oblongata—epilepsy syndrome	0.000429	0.0088	CbGeAlD
Docetaxel—TUBB6—Chlorthalidone—Clonazepam—epilepsy syndrome	0.000413	0.209	CbGdCrCtD
Docetaxel—MAP4—midbrain—epilepsy syndrome	0.000392	0.00804	CbGeAlD
Docetaxel—MAPT—cerebellum—epilepsy syndrome	0.000386	0.00791	CbGeAlD
Docetaxel—MAP4—spinal cord—epilepsy syndrome	0.000383	0.00785	CbGeAlD
Docetaxel—TUBB4A—brainstem—epilepsy syndrome	0.000375	0.00768	CbGeAlD
Docetaxel—TUBB4A—forebrain—epilepsy syndrome	0.000361	0.00741	CbGeAlD
Docetaxel—TUBB8—brain—epilepsy syndrome	0.000361	0.00741	CbGeAlD
Docetaxel—TUBB2B—forebrain—epilepsy syndrome	0.000349	0.00716	CbGeAlD
Docetaxel—MAP4—head—epilepsy syndrome	0.00034	0.00697	CbGeAlD
Docetaxel—TUBB3—head—epilepsy syndrome	0.00034	0.00697	CbGeAlD
Docetaxel—Cabazitaxel—ABCG2—epilepsy syndrome	0.000339	0.116	CrCbGaD
Docetaxel—MAP2—medulla oblongata—epilepsy syndrome	0.000338	0.00693	CbGeAlD
Docetaxel—TUBB1—head—epilepsy syndrome	0.000333	0.00682	CbGeAlD
Docetaxel—TUBB4A—telencephalon—epilepsy syndrome	0.000332	0.00681	CbGeAlD
Docetaxel—TUBB2A—forebrain—epilepsy syndrome	0.000329	0.00674	CbGeAlD
Docetaxel—MAP4—nervous system—epilepsy syndrome	0.000322	0.00661	CbGeAlD
Docetaxel—TUBB3—nervous system—epilepsy syndrome	0.000322	0.00661	CbGeAlD
Docetaxel—TUBB2B—telencephalon—epilepsy syndrome	0.000321	0.00659	CbGeAlD
Docetaxel—TUBB1—nervous system—epilepsy syndrome	0.000315	0.00646	CbGeAlD
Docetaxel—MAPT—brain—epilepsy syndrome	0.000313	0.00643	CbGeAlD
Docetaxel—MAP4—central nervous system—epilepsy syndrome	0.00031	0.00636	CbGeAlD
Docetaxel—TUBB3—central nervous system—epilepsy syndrome	0.00031	0.00636	CbGeAlD
Docetaxel—Paclitaxel—ABCC2—epilepsy syndrome	0.00031	0.106	CrCbGaD
Docetaxel—BCL2—head—epilepsy syndrome	0.000309	0.00634	CbGeAlD
Docetaxel—MAP2—midbrain—epilepsy syndrome	0.000309	0.00633	CbGeAlD
Docetaxel—TUBB—telencephalon—epilepsy syndrome	0.000304	0.00623	CbGeAlD
Docetaxel—TUBB1—central nervous system—epilepsy syndrome	0.000304	0.00622	CbGeAlD
Docetaxel—MAP4—cerebellum—epilepsy syndrome	0.000303	0.00622	CbGeAlD
Docetaxel—TUBB3—cerebellum—epilepsy syndrome	0.000303	0.00622	CbGeAlD
Docetaxel—TUBB2A—telencephalon—epilepsy syndrome	0.000302	0.0062	CbGeAlD
Docetaxel—MAP2—spinal cord—epilepsy syndrome	0.000301	0.00618	CbGeAlD
Docetaxel—BCL2—nervous system—epilepsy syndrome	0.000293	0.00601	CbGeAlD
Docetaxel—BCL2—central nervous system—epilepsy syndrome	0.000282	0.00579	CbGeAlD
Docetaxel—TUBB4B—forebrain—epilepsy syndrome	0.000282	0.00578	CbGeAlD
Docetaxel—KIF11—Niclosamide—Clonazepam—epilepsy syndrome	0.000276	0.14	CbGdCrCtD
Docetaxel—Paclitaxel—ABCG2—epilepsy syndrome	0.000274	0.0937	CrCbGaD
Docetaxel—EGFR—cerebellum—epilepsy syndrome	0.000273	0.00559	CbGeAlD
Docetaxel—MAP2—head—epilepsy syndrome	0.000268	0.00549	CbGeAlD
Docetaxel—TUBB4A—medulla oblongata—epilepsy syndrome	0.000261	0.00535	CbGeAlD
Docetaxel—ABCC10—telencephalon—epilepsy syndrome	0.000261	0.00535	CbGeAlD
Docetaxel—TUBB4B—telencephalon—epilepsy syndrome	0.000259	0.00532	CbGeAlD
Docetaxel—MAP2—nervous system—epilepsy syndrome	0.000254	0.00521	CbGeAlD
Docetaxel—TUBB6—Midazolam—Clonazepam—epilepsy syndrome	0.000254	0.129	CbGdCrCtD
Docetaxel—TUBB2B—medulla oblongata—epilepsy syndrome	0.000252	0.00517	CbGeAlD
Docetaxel—MAP4—brain—epilepsy syndrome	0.000246	0.00505	CbGeAlD
Docetaxel—TUBB3—brain—epilepsy syndrome	0.000246	0.00505	CbGeAlD
Docetaxel—MAP2—central nervous system—epilepsy syndrome	0.000244	0.00501	CbGeAlD
Docetaxel—TUBB1—brain—epilepsy syndrome	0.000241	0.00494	CbGeAlD
Docetaxel—MAP2—cerebellum—epilepsy syndrome	0.000239	0.0049	CbGeAlD
Docetaxel—TUBB—medulla oblongata—epilepsy syndrome	0.000239	0.0049	CbGeAlD
Docetaxel—TUBB4A—midbrain—epilepsy syndrome	0.000239	0.00489	CbGeAlD
Docetaxel—TUBB2A—medulla oblongata—epilepsy syndrome	0.000238	0.00487	CbGeAlD
Docetaxel—TUBB6—medulla oblongata—epilepsy syndrome	0.000234	0.0048	CbGeAlD
Docetaxel—TUBB4A—spinal cord—epilepsy syndrome	0.000233	0.00477	CbGeAlD
Docetaxel—TUBB6—Midazolam—Clobazam—epilepsy syndrome	0.000232	0.118	CbGdCrCtD
Docetaxel—TUBB2B—midbrain—epilepsy syndrome	0.000231	0.00473	CbGeAlD
Docetaxel—TUBB2B—spinal cord—epilepsy syndrome	0.000225	0.00461	CbGeAlD
Docetaxel—BCL2—brain—epilepsy syndrome	0.000224	0.00459	CbGeAlD
Docetaxel—EGFR—brain—epilepsy syndrome	0.000221	0.00454	CbGeAlD
Docetaxel—TUBB—midbrain—epilepsy syndrome	0.000218	0.00448	CbGeAlD
Docetaxel—TUBB2A—midbrain—epilepsy syndrome	0.000217	0.00445	CbGeAlD
Docetaxel—TUBB6—Midazolam—Diazepam—epilepsy syndrome	0.000216	0.109	CbGdCrCtD
Docetaxel—TUBB6—midbrain—epilepsy syndrome	0.000214	0.00439	CbGeAlD
Docetaxel—TUBB—spinal cord—epilepsy syndrome	0.000213	0.00437	CbGeAlD
Docetaxel—TUBB2A—spinal cord—epilepsy syndrome	0.000212	0.00434	CbGeAlD
Docetaxel—TUBB6—spinal cord—epilepsy syndrome	0.000209	0.00428	CbGeAlD
Docetaxel—TUBB4A—head—epilepsy syndrome	0.000207	0.00424	CbGeAlD
Docetaxel—CYP1B1—telencephalon—epilepsy syndrome	0.000205	0.00421	CbGeAlD
Docetaxel—ABCC10—medulla oblongata—epilepsy syndrome	0.000205	0.00421	CbGeAlD
Docetaxel—TUBB4B—medulla oblongata—epilepsy syndrome	0.000204	0.00418	CbGeAlD
Docetaxel—TUBB2B—head—epilepsy syndrome	0.0002	0.0041	CbGeAlD
Docetaxel—TUBB4A—nervous system—epilepsy syndrome	0.000196	0.00402	CbGeAlD
Docetaxel—MAP2—brain—epilepsy syndrome	0.000194	0.00398	CbGeAlD
Docetaxel—TUBB2B—nervous system—epilepsy syndrome	0.00019	0.00389	CbGeAlD
Docetaxel—TUBB4A—central nervous system—epilepsy syndrome	0.000189	0.00387	CbGeAlD
Docetaxel—TUBB2A—head—epilepsy syndrome	0.000188	0.00386	CbGeAlD
Docetaxel—ABCC10—midbrain—epilepsy syndrome	0.000188	0.00384	CbGeAlD
Docetaxel—TUBB4B—midbrain—epilepsy syndrome	0.000186	0.00382	CbGeAlD
Docetaxel—TUBB6—head—epilepsy syndrome	0.000186	0.00381	CbGeAlD
Docetaxel—ABCC1—telencephalon—epilepsy syndrome	0.000185	0.00379	CbGeAlD
Docetaxel—TUBB4A—cerebellum—epilepsy syndrome	0.000185	0.00379	CbGeAlD
Docetaxel—ABCC10—spinal cord—epilepsy syndrome	0.000183	0.00375	CbGeAlD
Docetaxel—TUBB2B—central nervous system—epilepsy syndrome	0.000183	0.00374	CbGeAlD
Docetaxel—TUBB4B—spinal cord—epilepsy syndrome	0.000182	0.00372	CbGeAlD
Docetaxel—TUBB2A—nervous system—epilepsy syndrome	0.000179	0.00366	CbGeAlD
Docetaxel—TUBB2B—cerebellum—epilepsy syndrome	0.000178	0.00366	CbGeAlD
Docetaxel—TUBB6—nervous system—epilepsy syndrome	0.000176	0.00361	CbGeAlD
Docetaxel—TUBB2A—central nervous system—epilepsy syndrome	0.000172	0.00352	CbGeAlD
Docetaxel—TUBB6—central nervous system—epilepsy syndrome	0.00017	0.00348	CbGeAlD
Docetaxel—TUBB—cerebellum—epilepsy syndrome	0.000169	0.00346	CbGeAlD
Docetaxel—TUBB2A—cerebellum—epilepsy syndrome	0.000168	0.00344	CbGeAlD
Docetaxel—SLC22A7—brain—epilepsy syndrome	0.000168	0.00344	CbGeAlD
Docetaxel—TUBB6—cerebellum—epilepsy syndrome	0.000166	0.0034	CbGeAlD
Docetaxel—TUBB4B—head—epilepsy syndrome	0.000161	0.00331	CbGeAlD
Docetaxel—TUBB4B—nervous system—epilepsy syndrome	0.000153	0.00314	CbGeAlD
Docetaxel—ABCG2—telencephalon—epilepsy syndrome	0.000153	0.00313	CbGeAlD
Docetaxel—TUBB4A—brain—epilepsy syndrome	0.00015	0.00308	CbGeAlD
Docetaxel—TUBB4B—central nervous system—epilepsy syndrome	0.000147	0.00302	CbGeAlD
Docetaxel—ABCC10—cerebellum—epilepsy syndrome	0.000145	0.00297	CbGeAlD
Docetaxel—TUBB2B—brain—epilepsy syndrome	0.000145	0.00297	CbGeAlD
Docetaxel—TUBB4B—Niclosamide—Clonazepam—epilepsy syndrome	0.000145	0.0735	CbGdCrCtD
Docetaxel—TUBB4B—cerebellum—epilepsy syndrome	0.000144	0.00295	CbGeAlD
Docetaxel—Cabazitaxel—ABCB1—epilepsy syndrome	0.000141	0.0483	CrCbGaD
Docetaxel—TUBB—brain—epilepsy syndrome	0.000137	0.00281	CbGeAlD
Docetaxel—TUBB2A—brain—epilepsy syndrome	0.000136	0.0028	CbGeAlD
Docetaxel—TUBB6—brain—epilepsy syndrome	0.000135	0.00276	CbGeAlD
Docetaxel—CYP1B1—head—epilepsy syndrome	0.000128	0.00262	CbGeAlD
Docetaxel—CYP1B1—nervous system—epilepsy syndrome	0.000121	0.00249	CbGeAlD
Docetaxel—TUBB6—Ethopropazine—Carbamazepine—epilepsy syndrome	0.000121	0.0615	CbGdCrCtD
Docetaxel—ABCG2—medulla oblongata—epilepsy syndrome	0.00012	0.00246	CbGeAlD
Docetaxel—ABCC10—brain—epilepsy syndrome	0.000118	0.00242	CbGeAlD
Docetaxel—TUBB4B—brain—epilepsy syndrome	0.000117	0.0024	CbGeAlD
Docetaxel—CYP1B1—central nervous system—epilepsy syndrome	0.000117	0.00239	CbGeAlD
Docetaxel—CYP1B1—cerebellum—epilepsy syndrome	0.000114	0.00234	CbGeAlD
Docetaxel—Paclitaxel—ABCB1—epilepsy syndrome	0.000114	0.039	CrCbGaD
Docetaxel—ABCG2—midbrain—epilepsy syndrome	0.00011	0.00225	CbGeAlD
Docetaxel—ABCG2—spinal cord—epilepsy syndrome	0.000107	0.0022	CbGeAlD
Docetaxel—ABCC1—cerebellum—epilepsy syndrome	0.000103	0.0021	CbGeAlD
Docetaxel—TUBB6—Nortriptyline—Oxcarbazepine—epilepsy syndrome	9.57e-05	0.0485	CbGdCrCtD
Docetaxel—CYP1B1—brain—epilepsy syndrome	9.27e-05	0.0019	CbGeAlD
Docetaxel—ABCG2—cerebellum—epilepsy syndrome	8.49e-05	0.00174	CbGeAlD
Docetaxel—ABCC1—brain—epilepsy syndrome	8.33e-05	0.00171	CbGeAlD
Docetaxel—ABCB1—forebrain—epilepsy syndrome	8.2e-05	0.00168	CbGeAlD
Docetaxel—TUBB6—Chlorprothixene—Midazolam—epilepsy syndrome	7.74e-05	0.0392	CbGdCrCtD
Docetaxel—ABCB1—telencephalon—epilepsy syndrome	7.54e-05	0.00155	CbGeAlD
Docetaxel—TUBB6—Niclosamide—Clonazepam—epilepsy syndrome	7.22e-05	0.0366	CbGdCrCtD
Docetaxel—ABCG2—brain—epilepsy syndrome	6.9e-05	0.00141	CbGeAlD
Docetaxel—TUBB6—Chlorprothixene—Diazepam—epilepsy syndrome	6.9e-05	0.035	CbGdCrCtD
Docetaxel—CYP3A4—nervous system—epilepsy syndrome	6.29e-05	0.00129	CbGeAlD
Docetaxel—CYP3A4—central nervous system—epilepsy syndrome	6.05e-05	0.00124	CbGeAlD
Docetaxel—ABCB1—medulla oblongata—epilepsy syndrome	5.92e-05	0.00121	CbGeAlD
Docetaxel—ABCB1—midbrain—epilepsy syndrome	5.41e-05	0.00111	CbGeAlD
Docetaxel—ABCB1—spinal cord—epilepsy syndrome	5.28e-05	0.00108	CbGeAlD
Docetaxel—ABCB1—head—epilepsy syndrome	4.7e-05	0.000963	CbGeAlD
Docetaxel—ABCB1—nervous system—epilepsy syndrome	4.45e-05	0.000913	CbGeAlD
Docetaxel—ABCB1—central nervous system—epilepsy syndrome	4.29e-05	0.000879	CbGeAlD
Docetaxel—ABCB1—cerebellum—epilepsy syndrome	4.19e-05	0.000859	CbGeAlD
Docetaxel—ABCB1—brain—epilepsy syndrome	3.4e-05	0.000698	CbGeAlD
Docetaxel—Pruritus—Phenytoin—epilepsy syndrome	2.81e-05	0.0002	CcSEcCtD
Docetaxel—Connective tissue disorder—Topiramate—epilepsy syndrome	2.81e-05	0.0002	CcSEcCtD
Docetaxel—Nausea—Levetiracetam—epilepsy syndrome	2.81e-05	0.0002	CcSEcCtD
Docetaxel—Rash—Vigabatrin—epilepsy syndrome	2.81e-05	0.000199	CcSEcCtD
Docetaxel—Dizziness—Felbamate—epilepsy syndrome	2.8e-05	0.000199	CcSEcCtD
Docetaxel—Dermatitis—Vigabatrin—epilepsy syndrome	2.8e-05	0.000199	CcSEcCtD
Docetaxel—Urethral disorder—Topiramate—epilepsy syndrome	2.8e-05	0.000199	CcSEcCtD
Docetaxel—Pruritus—Oxcarbazepine—epilepsy syndrome	2.8e-05	0.000199	CcSEcCtD
Docetaxel—Convulsion—Pregabalin—epilepsy syndrome	2.79e-05	0.000199	CcSEcCtD
Docetaxel—Hypersensitivity—Carbamazepine—epilepsy syndrome	2.79e-05	0.000199	CcSEcCtD
Docetaxel—Headache—Vigabatrin—epilepsy syndrome	2.79e-05	0.000198	CcSEcCtD
Docetaxel—Hypertension—Pregabalin—epilepsy syndrome	2.79e-05	0.000198	CcSEcCtD
Docetaxel—Vomiting—Diazepam—epilepsy syndrome	2.78e-05	0.000198	CcSEcCtD
Docetaxel—Anorexia—Valproic Acid—epilepsy syndrome	2.78e-05	0.000197	CcSEcCtD
Docetaxel—Rash—Diazepam—epilepsy syndrome	2.76e-05	0.000196	CcSEcCtD
Docetaxel—Dermatitis—Diazepam—epilepsy syndrome	2.76e-05	0.000196	CcSEcCtD
Docetaxel—Visual impairment—Topiramate—epilepsy syndrome	2.75e-05	0.000196	CcSEcCtD
Docetaxel—Myalgia—Pregabalin—epilepsy syndrome	2.75e-05	0.000195	CcSEcCtD
Docetaxel—Chest pain—Pregabalin—epilepsy syndrome	2.75e-05	0.000195	CcSEcCtD
Docetaxel—Arthralgia—Pregabalin—epilepsy syndrome	2.75e-05	0.000195	CcSEcCtD
Docetaxel—Dizziness—Zonisamide—epilepsy syndrome	2.74e-05	0.000195	CcSEcCtD
Docetaxel—Headache—Diazepam—epilepsy syndrome	2.74e-05	0.000195	CcSEcCtD
Docetaxel—Diarrhoea—Clonazepam—epilepsy syndrome	2.74e-05	0.000195	CcSEcCtD
Docetaxel—Anaemia—Gabapentin—epilepsy syndrome	2.73e-05	0.000194	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.73e-05	0.000194	CcSEcCtD
Docetaxel—Hypotension—Valproic Acid—epilepsy syndrome	2.72e-05	0.000193	CcSEcCtD
Docetaxel—Asthenia—Carbamazepine—epilepsy syndrome	2.72e-05	0.000193	CcSEcCtD
Docetaxel—Diarrhoea—Phenytoin—epilepsy syndrome	2.72e-05	0.000193	CcSEcCtD
Docetaxel—Nausea—Fosphenytoin—epilepsy syndrome	2.71e-05	0.000193	CcSEcCtD
Docetaxel—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.7e-05	0.000192	CcSEcCtD
Docetaxel—Erythema multiforme—Topiramate—epilepsy syndrome	2.7e-05	0.000192	CcSEcCtD
Docetaxel—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.7e-05	0.000192	CcSEcCtD
Docetaxel—Vomiting—Felbamate—epilepsy syndrome	2.7e-05	0.000192	CcSEcCtD
Docetaxel—Dry mouth—Pregabalin—epilepsy syndrome	2.69e-05	0.000191	CcSEcCtD
Docetaxel—Pruritus—Carbamazepine—epilepsy syndrome	2.68e-05	0.000191	CcSEcCtD
Docetaxel—Rash—Felbamate—epilepsy syndrome	2.67e-05	0.00019	CcSEcCtD
Docetaxel—Eye disorder—Topiramate—epilepsy syndrome	2.67e-05	0.00019	CcSEcCtD
Docetaxel—Dermatitis—Felbamate—epilepsy syndrome	2.67e-05	0.00019	CcSEcCtD
Docetaxel—Headache—Felbamate—epilepsy syndrome	2.66e-05	0.000189	CcSEcCtD
Docetaxel—Confusional state—Pregabalin—epilepsy syndrome	2.65e-05	0.000189	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.65e-05	0.000189	CcSEcCtD
Docetaxel—Cardiac disorder—Topiramate—epilepsy syndrome	2.65e-05	0.000189	CcSEcCtD
Docetaxel—Flushing—Topiramate—epilepsy syndrome	2.65e-05	0.000189	CcSEcCtD
Docetaxel—Syncope—Gabapentin—epilepsy syndrome	2.65e-05	0.000189	CcSEcCtD
Docetaxel—Leukopenia—Gabapentin—epilepsy syndrome	2.65e-05	0.000188	CcSEcCtD
Docetaxel—Dizziness—Clonazepam—epilepsy syndrome	2.64e-05	0.000188	CcSEcCtD
Docetaxel—Nausea—Vigabatrin—epilepsy syndrome	2.64e-05	0.000188	CcSEcCtD
Docetaxel—Vomiting—Zonisamide—epilepsy syndrome	2.64e-05	0.000188	CcSEcCtD
Docetaxel—Insomnia—Valproic Acid—epilepsy syndrome	2.63e-05	0.000187	CcSEcCtD
Docetaxel—Anaphylactic shock—Pregabalin—epilepsy syndrome	2.63e-05	0.000187	CcSEcCtD
Docetaxel—Oedema—Pregabalin—epilepsy syndrome	2.63e-05	0.000187	CcSEcCtD
Docetaxel—Asthenia—Lamotrigine—epilepsy syndrome	2.63e-05	0.000187	CcSEcCtD
Docetaxel—Dizziness—Phenytoin—epilepsy syndrome	2.63e-05	0.000187	CcSEcCtD
Docetaxel—Rash—Zonisamide—epilepsy syndrome	2.62e-05	0.000186	CcSEcCtD
Docetaxel—Infection—Pregabalin—epilepsy syndrome	2.62e-05	0.000186	CcSEcCtD
Docetaxel—Paraesthesia—Valproic Acid—epilepsy syndrome	2.61e-05	0.000186	CcSEcCtD
Docetaxel—Palpitations—Gabapentin—epilepsy syndrome	2.61e-05	0.000186	CcSEcCtD
Docetaxel—Dermatitis—Zonisamide—epilepsy syndrome	2.61e-05	0.000186	CcSEcCtD
Docetaxel—Dizziness—Oxcarbazepine—epilepsy syndrome	2.61e-05	0.000186	CcSEcCtD
Docetaxel—Nausea—Diazepam—epilepsy syndrome	2.6e-05	0.000185	CcSEcCtD
Docetaxel—Loss of consciousness—Gabapentin—epilepsy syndrome	2.6e-05	0.000185	CcSEcCtD
Docetaxel—Headache—Zonisamide—epilepsy syndrome	2.6e-05	0.000185	CcSEcCtD
Docetaxel—Dyspnoea—Valproic Acid—epilepsy syndrome	2.6e-05	0.000185	CcSEcCtD
Docetaxel—Diarrhoea—Carbamazepine—epilepsy syndrome	2.59e-05	0.000184	CcSEcCtD
Docetaxel—Angiopathy—Topiramate—epilepsy syndrome	2.59e-05	0.000184	CcSEcCtD
Docetaxel—Pruritus—Lamotrigine—epilepsy syndrome	2.59e-05	0.000184	CcSEcCtD
Docetaxel—Shock—Pregabalin—epilepsy syndrome	2.59e-05	0.000184	CcSEcCtD
Docetaxel—Somnolence—Valproic Acid—epilepsy syndrome	2.59e-05	0.000184	CcSEcCtD
Docetaxel—Immune system disorder—Topiramate—epilepsy syndrome	2.58e-05	0.000184	CcSEcCtD
Docetaxel—Nervous system disorder—Pregabalin—epilepsy syndrome	2.58e-05	0.000184	CcSEcCtD
Docetaxel—Cough—Gabapentin—epilepsy syndrome	2.58e-05	0.000184	CcSEcCtD
Docetaxel—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.58e-05	0.000183	CcSEcCtD
Docetaxel—Mediastinal disorder—Topiramate—epilepsy syndrome	2.58e-05	0.000183	CcSEcCtD
Docetaxel—Tachycardia—Pregabalin—epilepsy syndrome	2.57e-05	0.000183	CcSEcCtD
Docetaxel—Chills—Topiramate—epilepsy syndrome	2.57e-05	0.000182	CcSEcCtD
Docetaxel—Dyspepsia—Valproic Acid—epilepsy syndrome	2.56e-05	0.000182	CcSEcCtD
Docetaxel—Convulsion—Gabapentin—epilepsy syndrome	2.56e-05	0.000182	CcSEcCtD
Docetaxel—Skin disorder—Pregabalin—epilepsy syndrome	2.56e-05	0.000182	CcSEcCtD
Docetaxel—Hypertension—Gabapentin—epilepsy syndrome	2.55e-05	0.000182	CcSEcCtD
Docetaxel—Vomiting—Clonazepam—epilepsy syndrome	2.54e-05	0.000181	CcSEcCtD
Docetaxel—Decreased appetite—Valproic Acid—epilepsy syndrome	2.53e-05	0.00018	CcSEcCtD
Docetaxel—Alopecia—Topiramate—epilepsy syndrome	2.53e-05	0.00018	CcSEcCtD
Docetaxel—Vomiting—Phenytoin—epilepsy syndrome	2.53e-05	0.00018	CcSEcCtD
Docetaxel—Rash—Clonazepam—epilepsy syndrome	2.52e-05	0.000179	CcSEcCtD
Docetaxel—Dermatitis—Clonazepam—epilepsy syndrome	2.52e-05	0.000179	CcSEcCtD
Docetaxel—Myalgia—Gabapentin—epilepsy syndrome	2.52e-05	0.000179	CcSEcCtD
Docetaxel—Arthralgia—Gabapentin—epilepsy syndrome	2.52e-05	0.000179	CcSEcCtD
Docetaxel—Chest pain—Gabapentin—epilepsy syndrome	2.52e-05	0.000179	CcSEcCtD
Docetaxel—Nausea—Felbamate—epilepsy syndrome	2.52e-05	0.000179	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.51e-05	0.000179	CcSEcCtD
Docetaxel—Vomiting—Oxcarbazepine—epilepsy syndrome	2.51e-05	0.000179	CcSEcCtD
Docetaxel—Fatigue—Valproic Acid—epilepsy syndrome	2.51e-05	0.000179	CcSEcCtD
Docetaxel—Anorexia—Pregabalin—epilepsy syndrome	2.51e-05	0.000178	CcSEcCtD
Docetaxel—Dizziness—Carbamazepine—epilepsy syndrome	2.51e-05	0.000178	CcSEcCtD
Docetaxel—Diarrhoea—Lamotrigine—epilepsy syndrome	2.51e-05	0.000178	CcSEcCtD
Docetaxel—Headache—Clonazepam—epilepsy syndrome	2.51e-05	0.000178	CcSEcCtD
Docetaxel—Rash—Phenytoin—epilepsy syndrome	2.5e-05	0.000178	CcSEcCtD
Docetaxel—Mental disorder—Topiramate—epilepsy syndrome	2.5e-05	0.000178	CcSEcCtD
Docetaxel—Dermatitis—Phenytoin—epilepsy syndrome	2.5e-05	0.000178	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.5e-05	0.000178	CcSEcCtD
Docetaxel—Rash—Oxcarbazepine—epilepsy syndrome	2.49e-05	0.000177	CcSEcCtD
Docetaxel—Pain—Valproic Acid—epilepsy syndrome	2.49e-05	0.000177	CcSEcCtD
Docetaxel—Constipation—Valproic Acid—epilepsy syndrome	2.49e-05	0.000177	CcSEcCtD
Docetaxel—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.49e-05	0.000177	CcSEcCtD
Docetaxel—Headache—Phenytoin—epilepsy syndrome	2.49e-05	0.000177	CcSEcCtD
Docetaxel—Erythema—Topiramate—epilepsy syndrome	2.49e-05	0.000177	CcSEcCtD
Docetaxel—Malnutrition—Topiramate—epilepsy syndrome	2.49e-05	0.000177	CcSEcCtD
Docetaxel—Headache—Oxcarbazepine—epilepsy syndrome	2.48e-05	0.000176	CcSEcCtD
Docetaxel—Nausea—Zonisamide—epilepsy syndrome	2.46e-05	0.000175	CcSEcCtD
Docetaxel—Dry mouth—Gabapentin—epilepsy syndrome	2.46e-05	0.000175	CcSEcCtD
Docetaxel—Hypotension—Pregabalin—epilepsy syndrome	2.46e-05	0.000175	CcSEcCtD
Docetaxel—Dysgeusia—Topiramate—epilepsy syndrome	2.44e-05	0.000173	CcSEcCtD
Docetaxel—Confusional state—Gabapentin—epilepsy syndrome	2.43e-05	0.000173	CcSEcCtD
Docetaxel—Dizziness—Lamotrigine—epilepsy syndrome	2.42e-05	0.000172	CcSEcCtD
Docetaxel—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.41e-05	0.000172	CcSEcCtD
Docetaxel—Oedema—Gabapentin—epilepsy syndrome	2.41e-05	0.000172	CcSEcCtD
Docetaxel—Vomiting—Carbamazepine—epilepsy syndrome	2.41e-05	0.000171	CcSEcCtD
Docetaxel—Back pain—Topiramate—epilepsy syndrome	2.41e-05	0.000171	CcSEcCtD
Docetaxel—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.4e-05	0.000171	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.4e-05	0.000171	CcSEcCtD
Docetaxel—Infection—Gabapentin—epilepsy syndrome	2.4e-05	0.000171	CcSEcCtD
Docetaxel—Muscle spasms—Topiramate—epilepsy syndrome	2.39e-05	0.00017	CcSEcCtD
Docetaxel—Rash—Carbamazepine—epilepsy syndrome	2.39e-05	0.00017	CcSEcCtD
Docetaxel—Dermatitis—Carbamazepine—epilepsy syndrome	2.39e-05	0.00017	CcSEcCtD
Docetaxel—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.38e-05	0.000169	CcSEcCtD
Docetaxel—Insomnia—Pregabalin—epilepsy syndrome	2.38e-05	0.000169	CcSEcCtD
Docetaxel—Nausea—Clonazepam—epilepsy syndrome	2.38e-05	0.000169	CcSEcCtD
Docetaxel—Headache—Carbamazepine—epilepsy syndrome	2.38e-05	0.000169	CcSEcCtD
Docetaxel—Shock—Gabapentin—epilepsy syndrome	2.38e-05	0.000169	CcSEcCtD
Docetaxel—Nervous system disorder—Gabapentin—epilepsy syndrome	2.37e-05	0.000168	CcSEcCtD
Docetaxel—Paraesthesia—Pregabalin—epilepsy syndrome	2.36e-05	0.000168	CcSEcCtD
Docetaxel—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.36e-05	0.000168	CcSEcCtD
Docetaxel—Nausea—Phenytoin—epilepsy syndrome	2.36e-05	0.000168	CcSEcCtD
Docetaxel—Tachycardia—Gabapentin—epilepsy syndrome	2.36e-05	0.000168	CcSEcCtD
Docetaxel—Dyspnoea—Pregabalin—epilepsy syndrome	2.35e-05	0.000167	CcSEcCtD
Docetaxel—Nausea—Oxcarbazepine—epilepsy syndrome	2.35e-05	0.000167	CcSEcCtD
Docetaxel—Skin disorder—Gabapentin—epilepsy syndrome	2.34e-05	0.000167	CcSEcCtD
Docetaxel—Somnolence—Pregabalin—epilepsy syndrome	2.34e-05	0.000166	CcSEcCtD
Docetaxel—Vomiting—Lamotrigine—epilepsy syndrome	2.33e-05	0.000166	CcSEcCtD
Docetaxel—Rash—Lamotrigine—epilepsy syndrome	2.31e-05	0.000164	CcSEcCtD
Docetaxel—Dermatitis—Lamotrigine—epilepsy syndrome	2.31e-05	0.000164	CcSEcCtD
Docetaxel—Body temperature increased—Valproic Acid—epilepsy syndrome	2.3e-05	0.000164	CcSEcCtD
Docetaxel—Abdominal pain—Valproic Acid—epilepsy syndrome	2.3e-05	0.000164	CcSEcCtD
Docetaxel—Anorexia—Gabapentin—epilepsy syndrome	2.3e-05	0.000164	CcSEcCtD
Docetaxel—Anaemia—Topiramate—epilepsy syndrome	2.3e-05	0.000164	CcSEcCtD
Docetaxel—Headache—Lamotrigine—epilepsy syndrome	2.3e-05	0.000163	CcSEcCtD
Docetaxel—Decreased appetite—Pregabalin—epilepsy syndrome	2.29e-05	0.000163	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.27e-05	0.000162	CcSEcCtD
Docetaxel—Fatigue—Pregabalin—epilepsy syndrome	2.27e-05	0.000161	CcSEcCtD
Docetaxel—Hypotension—Gabapentin—epilepsy syndrome	2.26e-05	0.00016	CcSEcCtD
Docetaxel—Nausea—Carbamazepine—epilepsy syndrome	2.25e-05	0.00016	CcSEcCtD
Docetaxel—Constipation—Pregabalin—epilepsy syndrome	2.25e-05	0.00016	CcSEcCtD
Docetaxel—Pain—Pregabalin—epilepsy syndrome	2.25e-05	0.00016	CcSEcCtD
Docetaxel—Syncope—Topiramate—epilepsy syndrome	2.23e-05	0.000159	CcSEcCtD
Docetaxel—Leukopenia—Topiramate—epilepsy syndrome	2.23e-05	0.000158	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.2e-05	0.000156	CcSEcCtD
Docetaxel—Palpitations—Topiramate—epilepsy syndrome	2.2e-05	0.000156	CcSEcCtD
Docetaxel—Loss of consciousness—Topiramate—epilepsy syndrome	2.19e-05	0.000156	CcSEcCtD
Docetaxel—Insomnia—Gabapentin—epilepsy syndrome	2.18e-05	0.000155	CcSEcCtD
Docetaxel—Nausea—Lamotrigine—epilepsy syndrome	2.18e-05	0.000155	CcSEcCtD
Docetaxel—Cough—Topiramate—epilepsy syndrome	2.17e-05	0.000154	CcSEcCtD
Docetaxel—Feeling abnormal—Pregabalin—epilepsy syndrome	2.17e-05	0.000154	CcSEcCtD
Docetaxel—Paraesthesia—Gabapentin—epilepsy syndrome	2.17e-05	0.000154	CcSEcCtD
Docetaxel—Convulsion—Topiramate—epilepsy syndrome	2.16e-05	0.000153	CcSEcCtD
Docetaxel—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.15e-05	0.000153	CcSEcCtD
Docetaxel—Dyspnoea—Gabapentin—epilepsy syndrome	2.15e-05	0.000153	CcSEcCtD
Docetaxel—Hypertension—Topiramate—epilepsy syndrome	2.15e-05	0.000153	CcSEcCtD
Docetaxel—Somnolence—Gabapentin—epilepsy syndrome	2.15e-05	0.000153	CcSEcCtD
Docetaxel—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.15e-05	0.000153	CcSEcCtD
Docetaxel—Dyspepsia—Gabapentin—epilepsy syndrome	2.13e-05	0.000151	CcSEcCtD
Docetaxel—Myalgia—Topiramate—epilepsy syndrome	2.12e-05	0.000151	CcSEcCtD
Docetaxel—Chest pain—Topiramate—epilepsy syndrome	2.12e-05	0.000151	CcSEcCtD
Docetaxel—Arthralgia—Topiramate—epilepsy syndrome	2.12e-05	0.000151	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.1e-05	0.00015	CcSEcCtD
Docetaxel—Decreased appetite—Gabapentin—epilepsy syndrome	2.1e-05	0.000149	CcSEcCtD
Docetaxel—Asthenia—Valproic Acid—epilepsy syndrome	2.09e-05	0.000149	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.08e-05	0.000148	CcSEcCtD
Docetaxel—Fatigue—Gabapentin—epilepsy syndrome	2.08e-05	0.000148	CcSEcCtD
Docetaxel—Abdominal pain—Pregabalin—epilepsy syndrome	2.08e-05	0.000148	CcSEcCtD
Docetaxel—Body temperature increased—Pregabalin—epilepsy syndrome	2.08e-05	0.000148	CcSEcCtD
Docetaxel—Dry mouth—Topiramate—epilepsy syndrome	2.07e-05	0.000147	CcSEcCtD
Docetaxel—Pain—Gabapentin—epilepsy syndrome	2.06e-05	0.000147	CcSEcCtD
Docetaxel—Constipation—Gabapentin—epilepsy syndrome	2.06e-05	0.000147	CcSEcCtD
Docetaxel—Pruritus—Valproic Acid—epilepsy syndrome	2.06e-05	0.000147	CcSEcCtD
Docetaxel—Confusional state—Topiramate—epilepsy syndrome	2.05e-05	0.000146	CcSEcCtD
Docetaxel—Oedema—Topiramate—epilepsy syndrome	2.03e-05	0.000144	CcSEcCtD
Docetaxel—Infection—Topiramate—epilepsy syndrome	2.02e-05	0.000143	CcSEcCtD
Docetaxel—Shock—Topiramate—epilepsy syndrome	2e-05	0.000142	CcSEcCtD
Docetaxel—Diarrhoea—Valproic Acid—epilepsy syndrome	1.99e-05	0.000142	CcSEcCtD
Docetaxel—Nervous system disorder—Topiramate—epilepsy syndrome	1.99e-05	0.000142	CcSEcCtD
Docetaxel—Feeling abnormal—Gabapentin—epilepsy syndrome	1.99e-05	0.000141	CcSEcCtD
Docetaxel—Thrombocytopenia—Topiramate—epilepsy syndrome	1.99e-05	0.000141	CcSEcCtD
Docetaxel—Tachycardia—Topiramate—epilepsy syndrome	1.98e-05	0.000141	CcSEcCtD
Docetaxel—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.97e-05	0.00014	CcSEcCtD
Docetaxel—Skin disorder—Topiramate—epilepsy syndrome	1.97e-05	0.00014	CcSEcCtD
Docetaxel—Hypersensitivity—Pregabalin—epilepsy syndrome	1.94e-05	0.000138	CcSEcCtD
Docetaxel—Anorexia—Topiramate—epilepsy syndrome	1.94e-05	0.000138	CcSEcCtD
Docetaxel—Dizziness—Valproic Acid—epilepsy syndrome	1.93e-05	0.000137	CcSEcCtD
Docetaxel—Body temperature increased—Gabapentin—epilepsy syndrome	1.91e-05	0.000136	CcSEcCtD
Docetaxel—Abdominal pain—Gabapentin—epilepsy syndrome	1.91e-05	0.000136	CcSEcCtD
Docetaxel—Hypotension—Topiramate—epilepsy syndrome	1.9e-05	0.000135	CcSEcCtD
Docetaxel—Asthenia—Pregabalin—epilepsy syndrome	1.89e-05	0.000134	CcSEcCtD
Docetaxel—Pruritus—Pregabalin—epilepsy syndrome	1.86e-05	0.000132	CcSEcCtD
Docetaxel—Vomiting—Valproic Acid—epilepsy syndrome	1.85e-05	0.000132	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.85e-05	0.000132	CcSEcCtD
Docetaxel—Insomnia—Topiramate—epilepsy syndrome	1.84e-05	0.000131	CcSEcCtD
Docetaxel—Rash—Valproic Acid—epilepsy syndrome	1.84e-05	0.000131	CcSEcCtD
Docetaxel—Dermatitis—Valproic Acid—epilepsy syndrome	1.83e-05	0.00013	CcSEcCtD
Docetaxel—Headache—Valproic Acid—epilepsy syndrome	1.82e-05	0.00013	CcSEcCtD
Docetaxel—Paraesthesia—Topiramate—epilepsy syndrome	1.82e-05	0.00013	CcSEcCtD
Docetaxel—Dyspnoea—Topiramate—epilepsy syndrome	1.81e-05	0.000129	CcSEcCtD
Docetaxel—Somnolence—Topiramate—epilepsy syndrome	1.81e-05	0.000128	CcSEcCtD
Docetaxel—Diarrhoea—Pregabalin—epilepsy syndrome	1.8e-05	0.000128	CcSEcCtD
Docetaxel—Dyspepsia—Topiramate—epilepsy syndrome	1.79e-05	0.000127	CcSEcCtD
Docetaxel—Hypersensitivity—Gabapentin—epilepsy syndrome	1.78e-05	0.000126	CcSEcCtD
Docetaxel—Decreased appetite—Topiramate—epilepsy syndrome	1.77e-05	0.000126	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.75e-05	0.000125	CcSEcCtD
Docetaxel—Fatigue—Topiramate—epilepsy syndrome	1.75e-05	0.000125	CcSEcCtD
Docetaxel—Dizziness—Pregabalin—epilepsy syndrome	1.74e-05	0.000124	CcSEcCtD
Docetaxel—Constipation—Topiramate—epilepsy syndrome	1.74e-05	0.000124	CcSEcCtD
Docetaxel—Pain—Topiramate—epilepsy syndrome	1.74e-05	0.000124	CcSEcCtD
Docetaxel—Asthenia—Gabapentin—epilepsy syndrome	1.73e-05	0.000123	CcSEcCtD
Docetaxel—Nausea—Valproic Acid—epilepsy syndrome	1.73e-05	0.000123	CcSEcCtD
Docetaxel—Pruritus—Gabapentin—epilepsy syndrome	1.71e-05	0.000121	CcSEcCtD
Docetaxel—Vomiting—Pregabalin—epilepsy syndrome	1.67e-05	0.000119	CcSEcCtD
Docetaxel—Feeling abnormal—Topiramate—epilepsy syndrome	1.67e-05	0.000119	CcSEcCtD
Docetaxel—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.66e-05	0.000118	CcSEcCtD
Docetaxel—Rash—Pregabalin—epilepsy syndrome	1.66e-05	0.000118	CcSEcCtD
Docetaxel—Dermatitis—Pregabalin—epilepsy syndrome	1.66e-05	0.000118	CcSEcCtD
Docetaxel—Diarrhoea—Gabapentin—epilepsy syndrome	1.65e-05	0.000117	CcSEcCtD
Docetaxel—Headache—Pregabalin—epilepsy syndrome	1.65e-05	0.000117	CcSEcCtD
Docetaxel—Abdominal pain—Topiramate—epilepsy syndrome	1.61e-05	0.000114	CcSEcCtD
Docetaxel—Body temperature increased—Topiramate—epilepsy syndrome	1.61e-05	0.000114	CcSEcCtD
Docetaxel—Dizziness—Gabapentin—epilepsy syndrome	1.6e-05	0.000114	CcSEcCtD
Docetaxel—Nausea—Pregabalin—epilepsy syndrome	1.56e-05	0.000111	CcSEcCtD
Docetaxel—Vomiting—Gabapentin—epilepsy syndrome	1.53e-05	0.000109	CcSEcCtD
Docetaxel—Rash—Gabapentin—epilepsy syndrome	1.52e-05	0.000108	CcSEcCtD
Docetaxel—Dermatitis—Gabapentin—epilepsy syndrome	1.52e-05	0.000108	CcSEcCtD
Docetaxel—Headache—Gabapentin—epilepsy syndrome	1.51e-05	0.000108	CcSEcCtD
Docetaxel—Hypersensitivity—Topiramate—epilepsy syndrome	1.5e-05	0.000106	CcSEcCtD
Docetaxel—Asthenia—Topiramate—epilepsy syndrome	1.46e-05	0.000104	CcSEcCtD
Docetaxel—Pruritus—Topiramate—epilepsy syndrome	1.44e-05	0.000102	CcSEcCtD
Docetaxel—Nausea—Gabapentin—epilepsy syndrome	1.43e-05	0.000102	CcSEcCtD
Docetaxel—Diarrhoea—Topiramate—epilepsy syndrome	1.39e-05	9.88e-05	CcSEcCtD
Docetaxel—Dizziness—Topiramate—epilepsy syndrome	1.34e-05	9.55e-05	CcSEcCtD
Docetaxel—Vomiting—Topiramate—epilepsy syndrome	1.29e-05	9.18e-05	CcSEcCtD
Docetaxel—Rash—Topiramate—epilepsy syndrome	1.28e-05	9.11e-05	CcSEcCtD
Docetaxel—Dermatitis—Topiramate—epilepsy syndrome	1.28e-05	9.1e-05	CcSEcCtD
Docetaxel—Headache—Topiramate—epilepsy syndrome	1.27e-05	9.05e-05	CcSEcCtD
Docetaxel—Nausea—Topiramate—epilepsy syndrome	1.21e-05	8.58e-05	CcSEcCtD
Docetaxel—EGFR—Immune System—YWHAZ—epilepsy syndrome	2.08e-06	2.17e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—MTOR—epilepsy syndrome	2.07e-06	2.17e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—COX3—epilepsy syndrome	2.07e-06	2.17e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—SLC2A1—epilepsy syndrome	2.06e-06	2.16e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTK2B—epilepsy syndrome	2.06e-06	2.16e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TSC1—epilepsy syndrome	2.06e-06	2.16e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	2.06e-06	2.15e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PLCB1—epilepsy syndrome	2.06e-06	2.15e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—HES1—epilepsy syndrome	2.05e-06	2.15e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—TH—epilepsy syndrome	2.05e-06	2.15e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PLCB1—epilepsy syndrome	2.04e-06	2.13e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—YWHAZ—epilepsy syndrome	2.03e-06	2.13e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—TH—epilepsy syndrome	2.03e-06	2.13e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AGT—epilepsy syndrome	2.03e-06	2.12e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SST—epilepsy syndrome	2e-06	2.1e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCR2—epilepsy syndrome	2e-06	2.1e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NTRK2—epilepsy syndrome	2e-06	2.1e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—FYN—epilepsy syndrome	1.99e-06	2.09e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	1.99e-06	2.08e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—H2AFX—epilepsy syndrome	1.99e-06	2.08e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—DUSP6—epilepsy syndrome	1.99e-06	2.08e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.98e-06	2.07e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.96e-06	2.05e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.96e-06	2.05e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.96e-06	2.05e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.96e-06	2.05e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.96e-06	2.05e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ADRA2A—epilepsy syndrome	1.96e-06	2.05e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL1B—epilepsy syndrome	1.96e-06	2.05e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—SRC—epilepsy syndrome	1.96e-06	2.05e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.96e-06	2.05e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CCR5—epilepsy syndrome	1.96e-06	2.05e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PLAT—epilepsy syndrome	1.95e-06	2.04e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—HMOX1—epilepsy syndrome	1.94e-06	2.04e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AQP1—epilepsy syndrome	1.93e-06	2.02e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—JUN—epilepsy syndrome	1.93e-06	2.02e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CAT—epilepsy syndrome	1.92e-06	2.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—YWHAZ—epilepsy syndrome	1.92e-06	2.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—VEGFA—epilepsy syndrome	1.91e-06	2e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—JUN—epilepsy syndrome	1.9e-06	1.99e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	1.89e-06	1.97e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCL12—epilepsy syndrome	1.88e-06	1.97e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—BDKRB2—epilepsy syndrome	1.88e-06	1.97e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—AKT1—epilepsy syndrome	1.88e-06	1.97e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—HMOX1—epilepsy syndrome	1.88e-06	1.97e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PRKCB—epilepsy syndrome	1.88e-06	1.96e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL6ST—epilepsy syndrome	1.87e-06	1.96e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ABCB1—epilepsy syndrome	1.87e-06	1.95e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—TSC2—epilepsy syndrome	1.86e-06	1.94e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CRP—epilepsy syndrome	1.86e-06	1.94e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CAT—epilepsy syndrome	1.86e-06	1.94e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—JUNB—epilepsy syndrome	1.85e-06	1.94e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CNR1—epilepsy syndrome	1.85e-06	1.94e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CCR5—epilepsy syndrome	1.84e-06	1.93e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PLCB1—epilepsy syndrome	1.84e-06	1.93e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	1.84e-06	1.92e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	1.83e-06	1.91e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TSC2—epilepsy syndrome	1.82e-06	1.9e-05	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—AKT1—epilepsy syndrome	1.82e-06	1.9e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—POMC—epilepsy syndrome	1.81e-06	1.9e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ABCB1—epilepsy syndrome	1.81e-06	1.89e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HTR7—epilepsy syndrome	1.8e-06	1.89e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.79e-06	1.88e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.79e-06	1.88e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.79e-06	1.88e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—APOE—epilepsy syndrome	1.78e-06	1.86e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.76e-06	1.85e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HBEGF—epilepsy syndrome	1.75e-06	1.83e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CHRM3—epilepsy syndrome	1.75e-06	1.83e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	1.75e-06	1.83e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GPX1—epilepsy syndrome	1.74e-06	1.82e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—SRC—epilepsy syndrome	1.73e-06	1.81e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.73e-06	1.81e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKT3—epilepsy syndrome	1.72e-06	1.8e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—TSC2—epilepsy syndrome	1.71e-06	1.79e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PRKCB—epilepsy syndrome	1.71e-06	1.79e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—HMOX1—epilepsy syndrome	1.71e-06	1.79e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—POMC—epilepsy syndrome	1.71e-06	1.79e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL6ST—epilepsy syndrome	1.71e-06	1.79e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—SRC—epilepsy syndrome	1.7e-06	1.78e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	1.7e-06	1.78e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CAT—epilepsy syndrome	1.69e-06	1.77e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ADAM10—epilepsy syndrome	1.68e-06	1.76e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GPX1—epilepsy syndrome	1.68e-06	1.76e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—APOE—epilepsy syndrome	1.68e-06	1.76e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CAT—epilepsy syndrome	1.67e-06	1.75e-05	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—AKT1—epilepsy syndrome	1.67e-06	1.75e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IL6ST—epilepsy syndrome	1.67e-06	1.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CCL2—epilepsy syndrome	1.67e-06	1.75e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.67e-06	1.75e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.67e-06	1.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—SRC—epilepsy syndrome	1.66e-06	1.74e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NOS2—epilepsy syndrome	1.66e-06	1.74e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—ALB—epilepsy syndrome	1.65e-06	1.73e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	1.65e-06	1.73e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ABCB1—epilepsy syndrome	1.64e-06	1.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TNF—epilepsy syndrome	1.63e-06	1.71e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	1.63e-06	1.7e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—S100B—epilepsy syndrome	1.59e-06	1.66e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—IL6ST—epilepsy syndrome	1.58e-06	1.65e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SOCS3—epilepsy syndrome	1.57e-06	1.65e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.57e-06	1.64e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	1.57e-06	1.64e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CDC42—epilepsy syndrome	1.57e-06	1.64e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—FOS—epilepsy syndrome	1.56e-06	1.64e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—NOS2—epilepsy syndrome	1.56e-06	1.64e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—BCHE—epilepsy syndrome	1.56e-06	1.64e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CASP8—epilepsy syndrome	1.53e-06	1.6e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GPX1—epilepsy syndrome	1.53e-06	1.6e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.53e-06	1.6e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AGT—epilepsy syndrome	1.52e-06	1.59e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AVP—epilepsy syndrome	1.52e-06	1.59e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GPX1—epilepsy syndrome	1.51e-06	1.58e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—APOE—epilepsy syndrome	1.49e-06	1.56e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	1.49e-06	1.56e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.49e-06	1.56e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.49e-06	1.56e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	1.47e-06	1.54e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AGT—epilepsy syndrome	1.47e-06	1.54e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—TH—epilepsy syndrome	1.47e-06	1.54e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTGS2—epilepsy syndrome	1.44e-06	1.51e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—APOE—epilepsy syndrome	1.44e-06	1.51e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HES1—epilepsy syndrome	1.44e-06	1.5e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ABCG2—epilepsy syndrome	1.42e-06	1.49e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.42e-06	1.49e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.42e-06	1.49e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FYN—epilepsy syndrome	1.4e-06	1.46e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—H2AFX—epilepsy syndrome	1.39e-06	1.46e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MEF2C—epilepsy syndrome	1.39e-06	1.45e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.39e-06	1.45e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	1.39e-06	1.45e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—FGF2—epilepsy syndrome	1.38e-06	1.45e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	1.38e-06	1.44e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.36e-06	1.42e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—FGF2—epilepsy syndrome	1.35e-06	1.42e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—YWHAZ—epilepsy syndrome	1.34e-06	1.41e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AGT—epilepsy syndrome	1.34e-06	1.4e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.33e-06	1.4e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NGF—epilepsy syndrome	1.33e-06	1.39e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AGT—epilepsy syndrome	1.33e-06	1.39e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.31e-06	1.37e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—APOE—epilepsy syndrome	1.31e-06	1.37e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—BCL2—epilepsy syndrome	1.31e-06	1.37e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.31e-06	1.37e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—APOE—epilepsy syndrome	1.3e-06	1.36e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCR5—epilepsy syndrome	1.29e-06	1.35e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—RELA—epilepsy syndrome	1.28e-06	1.34e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—POMC—epilepsy syndrome	1.28e-06	1.34e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—FGF2—epilepsy syndrome	1.27e-06	1.33e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HTR2A—epilepsy syndrome	1.26e-06	1.32e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MTOR—epilepsy syndrome	1.26e-06	1.32e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	1.24e-06	1.3e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—POMC—epilepsy syndrome	1.24e-06	1.3e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MTOR—epilepsy syndrome	1.23e-06	1.29e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	1.23e-06	1.28e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.22e-06	1.28e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTGS2—epilepsy syndrome	1.22e-06	1.28e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—AKT1—epilepsy syndrome	1.22e-06	1.27e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CAT—epilepsy syndrome	1.21e-06	1.27e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TSC2—epilepsy syndrome	1.2e-06	1.26e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AGT—epilepsy syndrome	1.2e-06	1.26e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.19e-06	1.24e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.19e-06	1.24e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	1.18e-06	1.24e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—BCHE—epilepsy syndrome	1.18e-06	1.23e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	1.18e-06	1.23e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—APOE—epilepsy syndrome	1.17e-06	1.23e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ALB—epilepsy syndrome	1.17e-06	1.22e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MTOR—epilepsy syndrome	1.16e-06	1.21e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL1B—epilepsy syndrome	1.16e-06	1.21e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KDR—epilepsy syndrome	1.15e-06	1.2e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTGS2—epilepsy syndrome	1.15e-06	1.2e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ALB—epilepsy syndrome	1.13e-06	1.18e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—POMC—epilepsy syndrome	1.13e-06	1.18e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	1.12e-06	1.18e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—JUN—epilepsy syndrome	1.12e-06	1.18e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—POMC—epilepsy syndrome	1.12e-06	1.17e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PLCB1—epilepsy syndrome	1.11e-06	1.16e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—TH—epilepsy syndrome	1.11e-06	1.16e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PRKCB—epilepsy syndrome	1.11e-06	1.16e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL6ST—epilepsy syndrome	1.1e-06	1.16e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GPX1—epilepsy syndrome	1.09e-06	1.15e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.08e-06	1.13e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.08e-06	1.13e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—AKT1—epilepsy syndrome	1.07e-06	1.12e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—AKT1—epilepsy syndrome	1.06e-06	1.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—AKT1—epilepsy syndrome	1.03e-06	1.08e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ALB—epilepsy syndrome	1.03e-06	1.08e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTGS2—epilepsy syndrome	1.02e-06	1.07e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ALB—epilepsy syndrome	1.02e-06	1.07e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—POMC—epilepsy syndrome	1.01e-06	1.06e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—SRC—epilepsy syndrome	1.01e-06	1.05e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTGS2—epilepsy syndrome	9.88e-07	1.03e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCL2—epilepsy syndrome	9.88e-07	1.03e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SRC—epilepsy syndrome	9.86e-07	1.03e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AGT—epilepsy syndrome	9.59e-07	1e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—APOE—epilepsy syndrome	9.4e-07	9.84e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—SRC—epilepsy syndrome	9.3e-07	9.73e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—HMOX1—epilepsy syndrome	9.25e-07	9.68e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CAT—epilepsy syndrome	9.13e-07	9.55e-06	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTGS2—epilepsy syndrome	8.99e-07	9.41e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FGF2—epilepsy syndrome	8.93e-07	9.34e-06	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	8.91e-07	9.33e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	8.77e-07	9.18e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	8.54e-07	8.94e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	8.49e-07	8.89e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RELA—epilepsy syndrome	8.29e-07	8.67e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GPX1—epilepsy syndrome	8.25e-07	8.64e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MTOR—epilepsy syndrome	8.12e-07	8.51e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—POMC—epilepsy syndrome	8.07e-07	8.45e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	7.66e-07	8.02e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CASP3—epilepsy syndrome	7.47e-07	7.82e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ALB—epilepsy syndrome	7.36e-07	7.71e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	7.29e-07	7.64e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—BCHE—epilepsy syndrome	7.26e-07	7.6e-06	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—AKT1—epilepsy syndrome	7.26e-07	7.6e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—JUN—epilepsy syndrome	7.26e-07	7.6e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AGT—epilepsy syndrome	7.24e-07	7.58e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—APOE—epilepsy syndrome	7.09e-07	7.42e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MMP9—epilepsy syndrome	7.06e-07	7.39e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	6.93e-07	7.25e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	6.85e-07	7.17e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AKT1—epilepsy syndrome	6.85e-07	7.17e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—TH—epilepsy syndrome	6.83e-07	7.15e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SRC—epilepsy syndrome	6.51e-07	6.82e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	6.44e-07	6.74e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—VEGFA—epilepsy syndrome	6.34e-07	6.64e-06	CbGpPWpGaD
Docetaxel—EGFR—Immune System—AKT1—epilepsy syndrome	6.26e-07	6.55e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—AKT1—epilepsy syndrome	6.13e-07	6.42e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—POMC—epilepsy syndrome	6.09e-07	6.38e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—AKT1—epilepsy syndrome	5.78e-07	6.05e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	5.7e-07	5.97e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CAT—epilepsy syndrome	5.62e-07	5.89e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ALB—epilepsy syndrome	5.55e-07	5.81e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	5.47e-07	5.73e-06	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AKT1—epilepsy syndrome	5.13e-07	5.37e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GPX1—epilepsy syndrome	5.09e-07	5.32e-06	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AKT1—epilepsy syndrome	4.97e-07	5.2e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTGS2—epilepsy syndrome	4.86e-07	5.09e-06	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AKT1—epilepsy syndrome	4.52e-07	4.73e-06	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AKT1—epilepsy syndrome	4.48e-07	4.69e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AGT—epilepsy syndrome	4.46e-07	4.67e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—APOE—epilepsy syndrome	4.37e-07	4.57e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKT1—epilepsy syndrome	4.05e-07	4.24e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—POMC—epilepsy syndrome	3.75e-07	3.93e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALB—epilepsy syndrome	3.42e-07	3.58e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AKT1—epilepsy syndrome	3.24e-07	3.39e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.99e-07	3.13e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AKT1—epilepsy syndrome	2.44e-07	2.56e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.5e-07	1.58e-06	CbGpPWpGaD
